These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21474662)

  • 41. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
    Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Porcine malignant hyperthermia induced by halothane and succinylcholine: failure of treatment with procaine or procainamide.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Feb; 44(2):124-32. PubMed ID: 3127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo whole-body resting energy expenditure and insulin action in human malignant hyperthermia.
    Freymond D; Dériaz O; Frascarolo P; Reiz S; Jéquier E; Urwyler A
    Anesthesiology; 2000 Jul; 93(1):39-47. PubMed ID: 10861144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the 5-HT2 receptor antagonist ritanserin on halothane-induced increase of inositol phosphates in porcine malignant hyperthermia.
    Richter A; Scholz J; Löscher W; Tonner PH; Wappler F
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):593-7. PubMed ID: 8938657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia.
    Ording H; Fonsmark L
    Br J Anaesth; 1988 Mar; 60(4):445-9. PubMed ID: 2895665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prior hypothermia attenuates malignant hyperthermia in susceptible swine.
    Iaizzo PA; Kehler CH; Carr RJ; Sessler DI; Belani KG
    Anesth Analg; 1996 Apr; 82(4):803-9. PubMed ID: 8615501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Norepinephrine does not potentiate porcine malignant hyperthermia.
    Maccani RM; Wedel DJ; Hofer RE
    Anesth Analg; 1996 Apr; 82(4):790-5. PubMed ID: 8615499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of statin intake on malignant hyperthermia: an in vitro and in vivo swine study.
    Gonzalez A; Iles TL; Iaizzo PA; Bandschapp O
    BMC Anesthesiol; 2020 Oct; 20(1):270. PubMed ID: 33096987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study].
    Schuster F; Hager M; Metterlein T; Muellenbach RM; Wurmb T; Wunder C; Roewer N; Anetseder M
    Anaesthesist; 2008 Aug; 57(8):767-74. PubMed ID: 18563374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia.
    Textor Z; Beer M; Anetseder M; Köstler H; Kagerbauer E; Kenn W; Hahn D; Roewer N
    Muscle Nerve; 2003 Sep; 28(3):353-8. PubMed ID: 12929196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Halothane sensitivity of young pigs in vivo and in vitro.
    Fay RS; Gallant EM
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R133-8. PubMed ID: 2375422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnesium sulfate - An effective agent could delay the progression of fulminant malignant hyperthermia.
    Xu X
    Med Hypotheses; 2019 Mar; 124():118-120. PubMed ID: 30798905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic effects as a cause of myotoxic effects of fluoroquinolones.
    Metterlein T; Schuster F; Hager M; Roewer N; Anetseder M
    Indian J Pharmacol; 2015; 47(6):616-9. PubMed ID: 26729952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Porcine malignant hyperthermia. I: Metabolic and physiological changes.
    Lucke JN; Hall GM; Lister D
    Br J Anaesth; 1976 Apr; 48(4):297-304. PubMed ID: 1275996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia.
    Schütte JK; Schäfer U; Becker S; Oldewurtel C; Starosse A; Singler P; Richard A; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2013 Jan; 30(1):29-37. PubMed ID: 23138574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Halothane-induced porcine malignant hyperthermia: metabolic and hemodynamic changes.
    Gronert GA; Theye RA
    Anesthesiology; 1976 Jan; 44(1):36-43. PubMed ID: 1244773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xenon does not trigger malignant hyperthermia in susceptible swine.
    Froeba G; Marx T; Pazhur J; Baur C; Baeder S; Calzia E; Eichinger HM; Radermacher P; Georgieff M
    Anesthesiology; 1999 Oct; 91(4):1047-52. PubMed ID: 10519508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia.
    Ording H; Nielsen VG
    Br J Anaesth; 1986 Sep; 58(9):1001-4. PubMed ID: 3092848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.